Monday , 25 March 2019
Breaking News

Tag Archives: approval

Glenmark’s arm gets USFDA’s final approval for Clindamycin, Benzoyl Peroxide Gel

Glenmark Pharmaceuticals’ subsidiary — Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Clindamycin and Benzoyl Peroxide Gel, 1%/5%, a generic version of BenzaClin Gel, 1%/5%, of Valeant Bermuda. According to IQVIA sales data for the 12 month period ending January 2019, the BenzaClin Gel, 1%/5% market achieved annual ... Read More »

CMI jumps on getting vendor approval from various companies

CMI scrip is currently trading at Rs. 159.00, up by 10.30 points or 6.93% from its previous closing of Rs. 148.70 on the BSE. The scrip opened at Rs. 155.00 and has touched a high and low of Rs. 162.05 and Rs. 152.50 respectively. So far 4147 shares were traded on the counter. The BSE group ‘B’ stock of face ... Read More »

Trinity League India gets approval to ink MoU with ‘2050.Digital’

Trinity League India has received approval to sign Memorandum of Understanding (MoU) with ‘2050.Digital’ based in Russia, regarding availing of logistical support and technological solution for verification of insurance claim in agriculture sector. The Board of Directors of the company at its meeting held on March 14, 2019 approved the same. Trinity League India is engaged in the manufacture of ... Read More »

PVP Ventures receives approval for scheme of amalgamation

has received approval for the scheme of amalgamation amongst PVP Ventures, Picturehouse Media, PVP Media and PVP Cinema & their respective Shareholders and Creditors. The scheme of amalgamation of PVP Cinema, wholly owned subsidiary of Picturehouse Media with Picturehouse Media, parent company and amalgamation of PVP Media Ventures, wholly owned subsidiary of PVP Ventures and Picturehouse Media with PVP Ventures. ... Read More »

Zydus Wellness gets approval to raise Rs 1,500 crore via NCDs

Zydus Wellness has received approval to raise funds of aggregate nominal value up to Rs 1,500 crore through issuance of rated, secured, listed, redeemable, Non-Convertible Debentures (NCDs) each having a face value of Rs 10 lakh on private placement basis. The Board of Directors of the Company at its meeting held on January 11, 2019 has approved the same. Zydus ... Read More »

Tata Steel BSL gets approval to raise funds via NCRPS

Tata Steel BSL has received approval to raise funds through issuance of Non-Convertible Redeemable Preference Shares (NCRPS) to Tata Steel, on a private placement basis for an amount not exceeding to Rs 12,000 crore. The Board of Directors of the Company at its meeting held on January 09, 2019 has approved the same. Tata Steel BSL formerly known as Bhushan ... Read More »

Zydus receives approval from USFDA for Clindamycin Phosphate and Benzoyl Peroxide Gel

Zydus Cadila has received the final approval from the USFDA to market Clindamycin Phosphate and Benzoyl Peroxide Gel, (US RLD-DUAC Gel), 1.2%/5%. It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad. This combination medication is used to treat a certain type of acne (inflammatory acne vulgaris). It helps to decrease the number of acne pimples. Clindamycin is ... Read More »

NTPC gets investment approval for Solar PV Project

NTPC has received investment approval for Bilhaur Solar PV Project of 140 MW capacity and Auraiya Solar PV Project of 20 MW capacity. Earlier on October 10, 2018, the company participated for 160 MW Solar capacities in Uttar Pradesh and has won the entire capacity bid by it, comprising 140 MW at a levelised tariff of Rs 3.17/unit and 20 ... Read More »

Zydus Cadila gets USFDA’s approval for Nystatin and Triamcinolone Acetonide Ointment

Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Nystatin and Triamcinolone Acetonide Ointment USP, (US RLD -Mycolog-II Ointment), 100,000 units/gram and 1 mg/gram. It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad. It is used to treat fungal skin infections. This product contains nystatin, an anti-fungal drug ... Read More »

Alembic Pharma receives USFDA’s tentative approval for Alogliptin Tablet

Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Alogliptin Tablets, 6.25 mg, 12.5 mg and 25mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), NESINA Tablets, 6.25 mg, 12.5 mg and 25mg of Takeda Pharms USA. Alogliptin Tablets, 6.25 mg, 12.5 ... Read More »